All stocks / RVRC
Revium Rx. RVRC
Revium Rx (RVRC): a late 10-Q notice in November 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- REVIUM RECOVERY INC
- Market tier
- OTC Pink Current
- Trading status
- Active
- Last trade
- Nov 11
- Website
- www.revolutionresourcescorp.com/
The financial report, and what it means
Annual figures to 2025-12-31- Net loss
- ($13,449,000)
It spends more than it earns
Under strainThe company lost $13.4 million in the year. It reported no sales.
- Total assets
- $8,296,000
- Total liabilities
- $1,415,000
It owns more than it owes
SteadyEverything the company owns adds up to $8.3 million. Its debts and unpaid bills add up to $1.4 million. That is about $0.17 owed for every $1 owned.
What this adds up to
1 of 2 checks show strain. It spends more than it earns. These are facts from the company's own reports, not a recommendation.
Signals
Filed NT 10-Q on 2026-11-16: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Estimated float about 60,729,100 shares as of 2026-08-13: 60,729,100 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
| 2026-11-16 | NT 10-Q | NOTIFICATION OF LATE FILING |
| 2026-08-13 | 10-Q | QUARTERLY REPORT |
| 2026-06-22 | 8-K | CURRENT REPORT |
| 2026-06-01 | 8-K | CURRENT REPORT |
| 2026-05-14 | 10-Q | QUARTERLY REPORT |
| 2026-04-20 | 8-K | CURRENT REPORT |
| 2026-03-31 | 10-K | ANNUAL REPORT |
| 2026-01-30 | EFFECT | |
| 2026-01-28 | S-1/A | AMENDMENT NO. 5 TO FORM S-1 |
| 2026-01-16 | S-1/A | AMENDMENT NO. 4 TO FORM S-1 |
| 2025-12-12 | S-1/A | AMENDMENT NO. 3 TO FORM S-1 |
Common questions about RVRC
Does RVRC file reports with the SEC?
Yes. Revium Rx files with the SEC under company number 0001839140. The most recent filing we hold is a NT 10-Q dated 2026-11-16.
Source recordHow many RVRC shares are outstanding?
60,729,100 shares as of 2026-08-13, as reported to the SEC.
Source recordHas RVRC filed reports late?
Yes. In the last 12 months it filed 1 late-filing notice, most recently a NT 10-Q on 2026-11-16. A notice means a report was not ready on time; check whether the report followed.
Source recordIs Revium Rx making money?
The company lost $13.4 million in the year. It reported no sales. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record